Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
What are the most effective treatments for patients with multidrug-resistant HIV? Are there any new approaches being taken?
People who have multidrug resistant virus to HIV, most of them these days, the good news, can still be successfully be treated with our existing agents, the ones that are already FDA approved. The key sometimes is getting that person seen by an HIV specialist. This is really one of those areas where HIV expertise, clinical expertise, truly matters.
But, let’s imagine you have a patient who has seen that HIV expert and, still, they can’t be successfully treated because they have resistant virus. We do have a new tool, and that is the drug ibalizumab, which is an infusional monoclonal antibody that has activity against viruses that are resistant to all the other drug classes. So, that’s one potential option. There is also in clinical trials right now a drug called fostemsavir that’s not available yet but should be available in the not too distant future that could be used for that same patient population.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More